Interleukin-1α downregulates extracellular-superoxide dismutase in human corneal keratoconus stromal cells

Molecular Vision

Volumn 13, Issue , 2007, Pages 1285-1290

  Olofsson, Eva M ^a   Marklund, Stefan L ^a   Pedrosa Domellöf, Fatima ^a   Behndig, Anders ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD34 ANTIGEN; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; PLATELET DERIVED GROWTH FACTOR; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA; SOD3 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; CORNEA CELL; CORNEA INJURY; CORNEA STROMA; CORNEA TRANSPLANTATION; CULTURE MEDIUM; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; IMMUNOCHEMISTRY; INFLAMMATION; KERATOCONUS; KERATOPATHY; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; UPREGULATION; BIOSYNTHESIS; CELL DEATH; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; FIBROBLAST; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY;

CELL DEATH; CELLS, CULTURED; CORNEAL STROMA; DOWN-REGULATION; FIBROBLASTS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1ALPHA; KERATOCONUS; SUPEROXIDE DISMUTASE;

EID: 34547216853     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. McCord JM, Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 1969; 244:6049-55.
2. Marklund SL. Human copper-containing superoxide dismutase of high molecular weight. Proc Natl Acad Sci USA 1982; 79:7634-8.
3. Behndig A, Svensson B, Marklund SL, Karlsson K. Superoxide dismutase isoenzymes in the human eye. Invest Ophthalmol Vis Sci 1998; 39:471-5.
4. Poole CA, Brookes NH, Clover GM. Confocal imaging of the human keratocyte network using the vital dye 5-chloromethylfluorescein diacetate. Clin Experiment Ophthalmol 2003; 31:147-54.
5. Kenney MC, Brown DJ, Rajeev B. Everett Kinsey lecture. The elusive causes of keratoconus: a working hypothesis. CLAO J 2000; 26:10-3.
6. Buddi R, Lin B, Atilano SR, Zorapapel NC, Kenney MC, Brown DJ. Evidence of oxidative stress in human corneal diseases. J Histochem Cytochem 2002; 50:341-51.
7. Cristina Kenney M, Brown DJ. The cascade hypothesis of keratoconus. Cont Lens Anterior Eye 2003; 26:139-46.
8. Kenney MC, Chwa M, Atilano SR, Tran A, Carballo M, Saghizadeh M, Vasiliou V, Adachi W, Brown DJ. Increased levels of catalase and cathepsin V/L2 but decreased TIMP-1 in keratoconus corneas: evidence that oxidative stress plays a role in this disorder. Invest Ophthalmol Vis Sci 2005; 46:823-32.
9. Atilano SR, Coskun P, Chwa M, Jordan N, Reddy V, Le K, Wallace DC, Kenney MC. Accumulation of mitochondrial DNA damage in keratoconus corneas. Invest Ophthalmol Vis Sci 2005; 46:1256-63.
10. Behndig A, Karlsson K, Johansson BO, Brannstrom T, Marklund SL. Superoxide dismutase isoenzymes in the normal and diseased human cornea. Invest Ophthalmol Vis Sci 2001; 42:2293-6.
11. Klyce SD, Beuermann RW. Structure and function of the cornea. In: Kaufman HE, Barron BA, McDonald MB, editors. The cornea. 2nd ed. Boston, MA: Butterworth-Heinemann; 1998. p. 3-50.
12. Stralin P, Marklund SL. Effects of oxidative stress on expression of extracellular superoxide dismutase, CuZn-superoxide dismutase and Mn-superoxide dismutase in human dermal fibroblasts. Biochem J 1994; 298:347-52.
13. Stralin P, Marklund SL. Multiple cytokines regulate the expression of extracellular superoxide dismutase in human vascular smooth muscle cells. Atherosclerosis 2000; 151:433-41.
14. Stralin P, Jacobsson H, Marklund SL. Oxidative stress, NO* and smooth muscle cell extracellular superoxide dismutase expression. Biochim Biophys Acta 2003; 1619:1-8.
15. Girard MT, Matsubara M, Fini ME. Transforming growth factor-beta and interleukin-1 modulate metalloproteinase expression by corneal stromal cells. Invest Ophthalmol Vis Sci 1991; 32:2441-54.
16. Wek-Mays JA, Sadow PM, Tobin TW, Strissel KJ, Cintron C, Fini ME. Repair phenotype in corneal fibroblasts is controlled by an interleukin-1 alpha autocrine feedback loop. Invest Ophthalmol Vis Sci 1997; 38:1367-79.
17. Kim WJ, Mohan RR, Mohan RR, Wilson SE. Effect of PDGF, IL-1 alpha, and BMP2/4 on corneal fibroblast chemotaxis: expression of the platelet-derived growth factor system in the cornea. Invest Ophthalmol Vis Sci 1999; 40:1364-72.
18. Saghizadeh M, Chwa M, Aoki A, Lin B, Pirouzmanesh A, Brown DJ, Ljubimov AV, Kenney MC. Altered expression of growth factors and cytokines in keratoconus, bullous keratopathy and diabetic human corneas. Exp Eye Res 2001; 73:179-89.
19. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-54.
20. Labarca C, Paigen K. A simple, rapid, and sensitive DNA assay procedure. Anal Biochem 1980; 102:344-52.
21. Wilson SE, Mohan RR, Mohan RR, Ambrosio R Jr, Hong J, Lee J. The corneal wound healing response: cytokine-mediated interaction of the epithelium, stroma, and inflammatory cells. Prog Retin Eye Res 2001; 20:625-37.
22. Sotozono C, He J, Matsumoto Y, Kita M, Imanishi J, Kinoshita S. Cytokine expression in the alkali-burned cornea. Curr Eye Res 1997; 16:670-6.
23. McMahon TT, Szczotka-Flynn L, Barr JT, Anderson RJ, Slaughter ME, Lass JH, Iyengar SK, CLEK Study Group. A new method for grading the severity of keratoconus: the Keratoconus Severity Score (KSS). Cornea 2006; 25:794-800.
24. Tang YG, Rabinowitz YS, Taylor KD, Li X, Hu M, Picornell Y, Yang H. Genomewide linkage scan in a multigeneration Caucasian pedigree identifies a novel locus for keratoconus on chromosome 5q14.3-q21.1. Genet Med 2005; 7:397-405.
25. Rabinowitz YS, Dong L, Wistow G. Gene expression profile studies of human keratoconus cornea for NEIBank: a novel cornea-expressed gene and the absence of transcripts for aquaporin 5. Invest Ophthalmol Vis Sci 2005; 46:1239-46.
26. Li X, Rabinowitz YS, Tang YG, Picornell Y, Taylor KD, Hu M, Yang H. Two-stage genome-wide linkage scan in keratoconus sib pair families. Invest Ophthalmol Vis Sci 2006; 47:3791-5.